These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 9033112

  • 1. Detection of anti-Entamoeba histolytica IgA salivary antibodies: evaluation of its diagnostic capability in a rural setting.
    Escandón Romero C, Gómez Hernández JL, Cabral Soto J, Hernández Ramos JM, Escobedo-de la Peña J, Olvera Alvarez J.
    Arch Med Res; 1997; 28 Spec No():306-8. PubMed ID: 9033112
    [No Abstract] [Full Text] [Related]

  • 2. Anti-E. histolytica IgA antibodies in saliva of E. histolytica or E.dispar infected individuals: longitudinal study of cohorts.
    Ramos F, Valenzuela O, Morán P, González E, Ramiro M, Cedillo R, Martínez MC, Gómez A, Muñoz O, Melendro EI, Ximénez C.
    Arch Med Res; 1997; 28 Spec No():327-9. PubMed ID: 9033120
    [No Abstract] [Full Text] [Related]

  • 3. Diagnostic methods for differentiation of Entamoeba histolytica and Entamoeba dispar in carriers: performance and clinical implications in a non-endemic setting.
    Visser LG, Verweij JJ, Van Esbroeck M, Edeling WM, Clerinx J, Polderman AM.
    Int J Med Microbiol; 2006 Oct; 296(6):397-403. PubMed ID: 16753339
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of Entamoeba histolytica proteolytic activity by human salivary IgA antibodies.
    Guerrero-Manríquez GG, Sánchez-Ibarra F, Avila EE.
    APMIS; 1998 Nov; 106(11):1088-94. PubMed ID: 9890272
    [Abstract] [Full Text] [Related]

  • 5. [National serologic survey. I. Study of antibodies against E. histolytica in a semirural locality on the Gulf of Mexico Coast].
    Gutiérrez G, Margáin JC, Castañeda R, Enríquez O, Aubanel M, Sepúlveda B.
    Arch Invest Med (Mex); 1974 Nov; 5 SUPPL 2():475-80. PubMed ID: 4376934
    [No Abstract] [Full Text] [Related]

  • 6. Detection of IgA anti-Entamoeba histolytica in the patients' saliva.
    El Hamshary EM, Arafa WA.
    J Egypt Soc Parasitol; 2004 Dec; 34(3 Suppl):1095-104. PubMed ID: 15658064
    [Abstract] [Full Text] [Related]

  • 7. [Prevalence of antibodies to Entamoeba histolytica in the Northern area of the Province of Huelva].
    Perea R, Bassas E, Lepe JA, Lombardo M, Garcés M.
    Med Clin (Barc); 1998 Feb 28; 110(7):275. PubMed ID: 9562953
    [No Abstract] [Full Text] [Related]

  • 8. Seroepidemiology of anti-Entamoeba histolytica antibody by enzyme-linked immunosorbent assay in the greater Tokyo area.
    Tanaka T, Kaneda Y.
    Tokai J Exp Clin Med; 1991 Dec 28; 16(5-6):253-8. PubMed ID: 1820666
    [Abstract] [Full Text] [Related]

  • 9. A seroepidemiological survey of amoebiasis in Lucknow.
    Khan AH, Ghosh PK, Das SR.
    Trop Gastroenterol; 1985 Dec 28; 6(1):30-6. PubMed ID: 2862724
    [No Abstract] [Full Text] [Related]

  • 10. Studies on the prevalence of Entamoeba histolytica in Iraq.
    Niazi AD, Al-Issa TB, Khamis F.
    Bull Endem Dis (Baghdad); 1976 Nov 28; 17(1-4):127-41. PubMed ID: 198048
    [No Abstract] [Full Text] [Related]

  • 11. [Amebiasis. Its epidemiology today].
    Gutiérrez Trujillo G, Muñoz Hernández O.
    Rev Gastroenterol Mex; 1989 Nov 28; 54(3):145-56. PubMed ID: 2554461
    [No Abstract] [Full Text] [Related]

  • 12. Protective immunity to entamoeba histolytica infection in subjects with antiamoebic antibodies residing in a hyperendemic zone.
    Choudhuri G, Prakash V, Kumar A, Shahi SK, Sharma M.
    Scand J Infect Dis; 1991 Nov 28; 23(6):771-6. PubMed ID: 1815341
    [Abstract] [Full Text] [Related]

  • 13. Entamoeba histolytica infection in children and protection from subsequent amebiasis.
    Haque R, Mondal D, Duggal P, Kabir M, Roy S, Farr BM, Sack RB, Petri WA.
    Infect Immun; 2006 Feb 28; 74(2):904-9. PubMed ID: 16428733
    [Abstract] [Full Text] [Related]

  • 14. Serological differentiation between zymodemes of Entamoeba histolytica.
    Demedts P, Coene J, Wéry M.
    J Trop Med Hyg; 1989 Apr 28; 92(2):121-2. PubMed ID: 2540346
    [No Abstract] [Full Text] [Related]

  • 15. Invasive amebiasis as an emerging parasitic disease in patients with human immunodeficiency virus type 1 infection in Taiwan.
    Hung CC, Deng HY, Hsiao WH, Hsieh SM, Hsiao CF, Chen MY, Chang SC, Su KE.
    Arch Intern Med; 2005 Feb 28; 165(4):409-15. PubMed ID: 15738369
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of enzyme-linked immunosorbent assay (ELISA), indirect hemagglutination (IHA), counterimmunoelectrophoresis (CIEP), and immunodiffusion (ID) in the serodiagnosis of amebiasis.
    Youssef FG, Mansour NS.
    J Egypt Soc Parasitol; 1988 Dec 28; 18(2):373-81. PubMed ID: 2901446
    [No Abstract] [Full Text] [Related]

  • 17. The prevalence of entamoeba histolytica and Toxoplasma gondii antibodies in Central Java, Indonesia.
    Cross JH, Irving GS, Gunawan S.
    Southeast Asian J Trop Med Public Health; 1975 Dec 28; 6(4):467-71. PubMed ID: 179151
    [Abstract] [Full Text] [Related]

  • 18. Infection by human immunodeficiency virus-1 is not a risk factor for amebiasis.
    Morán P, Ramos F, Ramiro M, Curiel O, González E, Valadez A, Gómez A, García G, Melendro EI, Ximénez C.
    Am J Trop Med Hyg; 2005 Aug 28; 73(2):296-300. PubMed ID: 16103593
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of an enzyme-immunoassay test kit for diagnosing infections with Entamoeba histolytica.
    Benzeguir AK, Aust Kettis A.
    Arch Med Res; 1997 Aug 28; 28 Spec No():276-8. PubMed ID: 9033100
    [No Abstract] [Full Text] [Related]

  • 20. Two rapid and simple enzyme immunoassays for human antibodies to Entamoeba histolytica.
    Lin TM, Schubert CM, Kiefer DJ, Troy S, Cort R, Giegel JL, Lin JH, Neill L.
    J Immunoassay; 1989 Aug 28; 10(4):301-13. PubMed ID: 2558127
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.